Anne Rullier Selected Research

Ligands

9/2007

The effect of body weight on altered expression of nuclear receptors and cyclooxygenase-2 in human colorectal cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anne Rullier Research Topics

Disease

15	Neoplasms (Cancer) 01/2021 - 08/2003
13	Rectal Neoplasms (Rectal Cancer) 10/2021 - 03/2005
5	Neoplasm Metastasis (Metastasis) 10/2021 - 06/2004
5	Hepatocellular Carcinoma (Hepatoma) 08/2009 - 04/2006
4	Carcinoma (Carcinomatosis) 01/2017 - 05/2005
3	Residual Neoplasm 01/2020 - 05/2005
2	Adenocarcinoma 10/2021 - 04/2010
2	Hepatoblastoma 01/2018 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 02/2012 - 09/2007
2	Liver Cell Adenoma (Hepatocellular Adenoma) 03/2009 - 09/2007
2	Fibrosis (Cirrhosis) 03/2009 - 09/2004
2	Body Weight (Weight, Body) 09/2007 - 01/2007
2	Colitis 01/2007 - 11/2005
1	Vascular Diseases (Vascular Disease) 05/2021
1	Atherosclerosis 05/2021
1	Ischemic Stroke 05/2021
1	Hodgkin Disease (Hodgkin's Disease) 01/2019
1	Neoplasm Micrometastasis 07/2015
1	Colonic Neoplasms (Colon Cancer) 07/2015
1	Margins of Excision 01/2013
1	Hemorrhage 08/2009
1	Focal Nodular Hyperplasia 03/2009
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2008
1	Necrosis 01/2008
1	Obesity 09/2007
1	Sepsis (Septicemia) 11/2006
1	Inflammation (Inflammations) 01/2006
1	Carcinogenesis 01/2006
1	Lymphatic Metastasis 06/2004
1	Infections 06/2003
1	Chronic Hepatitis C 06/2003

Drug/Important Bio-Agent (IBA)

4	beta CateninIBA 01/2017 - 09/2007
2	Proteins (Proteins, Gene)FDA Link 05/2021 - 01/2017
2	Thrombin FDA Link 01/2008 - 01/2006
2	Matrix Metalloproteinases (MMPs)IBA 01/2007 - 04/2006
1	ParaffinIBA 05/2021
1	Formaldehyde (Formol)FDA Link 05/2021
1	Immune Checkpoint InhibitorsIBA 01/2019
1	IntegrinsIBA 01/2018
1	Oxidoreductases (Dehydrogenase)IBA 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Bortezomib (Velcade)FDA Link 01/2018
1	VimentinIBA 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2017
1	CateninsIBA 01/2017
1	Biological ProductsIBA 01/2017
1	Cetuximab (Erbitux)FDA Link 07/2015
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2013
1	Capecitabine (Xeloda)FDA Link 01/2013
1	Biomarkers (Surrogate Marker)IBA 12/2011
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 03/2009
1	Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA 03/2009
1	Fatty Acid-Binding ProteinsIBA 03/2009
1	PAR-1 ReceptorIBA 01/2008
1	Transaminases (Aminotransferases)IBA 01/2008
1	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2008
1	LigandsIBA 09/2007
1	RetinoidsIBA 09/2007
1	Messenger RNA (mRNA)IBA 09/2007
1	Transcription Factors (Transcription Factor)IBA 09/2007
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 09/2007
1	PPAR deltaIBA 09/2007
1	PPAR gammaIBA 09/2007
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2007
1	Pravastatin (Pravachol)FDA LinkGeneric 01/2007
1	rebamipideIBA 01/2007
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2007
1	Protective AgentsIBA 01/2007
1	SolventsIBA 04/2006
1	halofuginoneIBA 04/2006
1	Thromboplastin (Tissue Factor)IBA 01/2006
1	Proteinase-Activated ReceptorsIBA 01/2006
1	Conditioned Culture MediaIBA 11/2005
1	Colloids (Colloid)IBA 05/2005
1	Carcinoembryonic AntigenIBA 06/2004
1	Protons (Proton)IBA 08/2003
1	Ribavirin (Virazole)FDA LinkGeneric 06/2003

Therapy/Procedure

8	Chemoradiotherapy 10/2021 - 01/2008
8	Neoadjuvant Therapy 10/2021 - 05/2005
6	Radiotherapy 01/2021 - 05/2005
6	Therapeutics 01/2019 - 09/2004
4	Drug Therapy (Chemotherapy) 01/2021 - 05/2005
2	Adjuvant Chemotherapy 07/2015 - 11/2006
2	Proctectomy 05/2013 - 03/2005
1	Induction Chemotherapy 10/2021
1	Carotid Endarterectomy 05/2021
1	Re-Irradiation 01/2021
1	Oral Administration 11/2005
1	Lymph Node Excision (Lymph Node Dissection) 06/2004
1	Induced Hyperthermia (Thermotherapy) 08/2003